Company: ARTL
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001640334-25-001240
Chunk: 0

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On July 18, 2025, Artelo Biosciences, Inc. (the “ Company”) entered into an At-The-Market Offering Agreement (the “ Sales Agreement”) with R. F. Lafferty & Co., Inc. (the “ Manager”) to create an at-the-market equity program under which it may sell up to an aggregate of $6,500,000 of shares of the Company’s common stock, par value $0.001 per share (the “ Shares”), from time to time through the Manager, as sales agent, subject to any applicable limits when using Form S-3 (the “ ATM Offering”).

Upon delivery of a sales notice and subject to the terms and conditions of the Sales Agreement, the Manager may sell the Company’s common stock by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act, including sales made directly on The Nasdaq Capital Market, on any other existing trading market for the common stock or to or through a market maker. If the Company and the Manager agree on any method of distribution other than sales of shares of the Company’s common stock into The Nasdaq Capital Market or another existing trading market in the United States at market prices, the Company will file a further prospectus supplement providing all information about such offering as required by Rule 424(b) under the Securities Act. The Company may instruct the Manager not to sell Shares if the sales cannot be effected at or above the price designated by the Company from time to time. The Company and the Manager may suspend the ATM Offering upon notice and subject to other conditions.

The Company will pay the Manager commissions, in cash, for its services in acting as agent in the sale of the Shares. The Manager will be entitled to compensation at a commission rate of 2.0% of the gross sales price per share of common stock sold. The Company will also reimburse the Manager for certain specified expenses in connection with the Sales Agreement. The Sales Agreement contains customary representations, warranties and agreements by the Company, indemnification obligations of the Company and the Manager, other obligations of the parties and termination provisions. The Company has no obligation to sell any of the Shares, and may at any time suspend offers under the Agreement.

The ATM Offering will terminate upon the earlier of (i) the sale of all shares of the Company’s common stock subject to the Sales Agreement or (ii) termination of